GlassScriptPhysician profile
Iulia R Platte
NPI 1437359981
$8,775.49
in general payments reported to CMS, 2019-2025
48 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,024 · 2020: $704 · 2021: $1,372 · 2022: $1,107 · 2023: $1,486 · 2024: $1,391 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,569.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,120.45 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $805.02 | 2019-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $762.46 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $742.57 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $720.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $717.94 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Abbvie INC. | $681.25 | 2020-2025 | |
| Glaxosmithkline, LLC. | $548.26 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $247.74 | 2019-2025 | Spravato |
| Abbott Laboratories | $239.41 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Merck Sharp & Dohme LLC | $218.25 | 2019-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Biohaven Pharmaceuticals, INC. | $159.52 | 2021 | |
| Exact Sciences Corporation | $139.40 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $114.21 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $89.33 | 2020-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iulia Platte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.